Medical malpractice attorneys at Pintas & Mullins Law Firm are carefully following the latest warnings from federal health officials about a possible link between Fosomax and rare femur fractures.
Several years after concerns first surfaced, the FDA issued a new warning for Fosomax and other biphsophonate drugs that are designed to make bones stronger. Instead of preserving the brittle bones of osteoporosis patients, research shows that the drugs may actually lead to a rare but serious type of thigh bone fracture. An increasing number of low trauma bone breaks have been reported among Fosomax users, particularly those who used the bone drug for five years or longer. In most cases, patients felt a dull, aching pain in the thigh or groin months before a complete fracture.
Fosomax was first approved in 1995, and has since been used by more than 20 million people.
Brittle bones are not the only dangerous side effect associated with Fosomax. A high number of lawsuits have been filed against Fosomax manufacturer Merck, claiming that the drug maker failed to warn users about the potential for another rare condition known as "dead jaw syndrome," which causes portions of the drug to decay or die. Merck also faces allegations that it failed to accurately research its medication or warn users about the risk of bone breaks.
Our attorneys at the Pintas & Mullins Law Firm are currently investigating the possible connection between Fosomax and these rare but serious conditions. If you are a Fosomax user and believe that you have been harmed by the drug, contact our firm immediately for a free consultation.